Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer. Read more about Targeted Biopsy Is Sufficient for Men on Active Surveillance for Early-Stage Prostate Cancer.
Reevaluating the Definition of Clinically Significant Prostate Cancer as Grade Groups 2 to 5: An Imperative for Improved Risk Stratification. Read more about Reevaluating the Definition of Clinically Significant Prostate Cancer as Grade Groups 2 to 5: An Imperative for Improved Risk Stratification.
Postvasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit. Read more about Postvasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit.
Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Sco Read more about Beyond Prostate Imaging Reporting and Data System: Combining Magnetic Resonance Imaging Prostate Imaging Reporting and Data System and Prostate-Specific Membrane Antigen-Positron Emission Tomography/Computed Tomography PRIMARY Score in a Composite (P) Sco
Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer. Read more about Representation Matters: Trust in Digital Health Information Among Black Patients With Prostate Cancer.
Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging. Read more about Stability of Prognostic Estimation Using the CAPRA Score Incorporating Imaging-based vs Physical Exam-based Staging.
Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation. Read more about Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.
